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Lifeline Resident Research Prize Paper
Vascular Smooth Muscle Enhances Functionality of
Tissue Engineered Blood Vessels In Vivo
Lucas P. Neff1, Bryan Tillman1, Saami Yazadani2, Masood
Machingal2, James Yoo2, Shay Soker2, Brian Bernish1, Ran-
dolph Geary1, George Christ2. 1Vascular Surgery, Wake
Forest University School of Medicine, Winston-Salem,
NC; 2Wake Forest Institute of Regenerative Medicine,
Winston-Salem, NC
Objectives: Physiologic responses of tissue engineered
blood vessels (TEBV) seeded with endothelial cells (EC)
remains suboptimal compared to native arteries due to lack
of smooth muscle cells (SMC) in the vessel media. Thus,
there may be benefit to incorporating SMCs into TEBV. In
vitro studies have shown limited vasomotor activity in SMC
seeded TEBV. The goal of the present study was to evaluate
the impact of SMC co-seeding on TEBV structure and
function after prolonged in vivo maturation.
Methods: DsTEBV TEBV (dsTEBV) were created
co-seeding autologous ECs derived from circulating pro-
genitor cells (EPC) and SMCs from artery explants onto
lumen and outer surface of extracellular matrix (ECM)
scaffolds, respectively. Controls were seeded with EC alone
(ecTEBV). All vessels were pre-conditioned to pulsatile
flow for 10-14 days in a bioreactor, implanted as arterial
interposition grafts in sheep, and allowed to heal and adapt
in vivo for 4 months before ex vivo physiological testing
and histological analysis.
Results: Five vessels were implanted in each group and all
were patent at 4 months. There were no structural failures,
aneurysms, or infectious complications. dsTEB vs exhibited a
greater degree of wall maturation characterized by higher
medial cellularity (p 0.01) and greater percentage of-actin
(p  0.005) and SMC-specific muscle myosin heavy chain
(sm-MHC, p  0.005) staining compared to ecTEB vs.
Vasomotor responses in hung rings of dsTEBV showed sig-
nificantlymore contraction in response to phenylephrine (p
0.01) and serotonin (p 0.01) than ecTEBV.
Conclusions: This is the first study to demonstrate
enhanced in vivo wall maturation and development of
contractile function when bioengineered vessels are co-
seeded with autologous SMC and EC compared to EC
seeding alone. These data suggest a co-seeding strategy can
be accomplished in a clinically relevant time frame (typically
6 weeks) and may prove superior for arterial reconstruction
compared to vessels engineered only with endothelium.
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SS2.
Evolution of Operative Strategies in Open Thoracoab-
dominal Aneurysm Repair (TAA)
Richard P. Cambria, Mark F. Conrad, Emel A. Ergul,
Virendra I. Patel, GlennM. LaMuraglia, Matthew R. Cam-
bria. Vascular Surgery, Massachusetts General Hospital,
Boston, MA
Objectives: Over a 24-year interval we managed most
(90%) of thoracoabdominal aortic aneurysms (TAA) with
a clamp and sew (CS) approach with protective adjuncts of
epidural cooling and aggressive intercostal reconstruction
(IC) to prevent spinal cord ischemia. A finite death/para-
plegia rate led to modifications using distal aortic perfusion
(DAP) via atriofemoral bypass to support cord collateral
circulation and selective IC based on motor evoked poten-
tial (MEP) monitoring. This study evaluates the early im-
pact of DAP on TAA outcomes.
Methods: Consecutive patients undergoing repair of
nonruptured Crawford extent I-III TAA using DAP/MEP
were compared to a propensity-matched cohort of patients
treated with CS. Outcomes include 30-day mortality and
paraplegia.
Results: There were 52 patients in the DAP cohort vs
127 undergoingCS. The cohorts differed in age (62.6 years
vs 69.5 years CS, p  0.0003), presence of Marfan’s (10%
DAP vs 2% CS, p  0.01), and chronic dissection (37%
DAP vs 8% CS, p  0.001). Mortality was low in both
groups (2% vs 5% CS, p  0.38); postoperative renal
insufficiency, albeit doubled in CS, was not significant (8%
DAP vs 17% CS, p  0.10). DAP had a significantly lower
incidence of IC than the CS group (10% DAP vs 34% CS,
p 0.0001), yet there was no paraplegia in the DAP cohort
(0% DAP vs 5% CS, p  0.11). The composite death/
paraplegia rate was decreased with DAP (1/52 (2%) DAP
vs 11/127 (9%) CS, p  0.01). Paraparesis with complete
recovery occurred in 5/52 (10%) of the DAP group.
Conclusions: Elective TAA repair was accomplished
with a low mortality in both the DAP and CS cohorts. The
use of MEP in the DAP cohort (despite higher risk because
of number of chronic dissections) decreased the need for IC
with no paraplegia to date. DAP with MEP is the preferred
operative strategy for TAA repair.
Author Disclosures: M. R. Cambria: Nothing to dis-
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SS3.
In Situ Rifampin-Soaked Grafts Are Durable With
Low Reinfection Rates in Patients With Aortic Graft
Enteric Erosion or Fistula
Gustavo S. Oderich, Thomas C. Bower, Jan Hofer, Manju
Kalra, Audra A. Duncan, Joseph J. Ricotta, Peter Gloviczki.
Division of Vascular and Endovascular Surgery, Mayo
Clinic, Rochester, MN
Objectives: We previously reported that in situ rifampin-
soaked grafts (ISR) were safe in selected patients with aortic
graft infections, with the best results in those with aortic
graft enteric erosion or fistula (AGEF). This study evaluates
the late results of ISR for AGEF.
Methods: From 1990 to 2008 183 patients were
treated for aortic graft infections (121 primary and 62
AGEF). We reviewed 54 patients treated for AGEF with a
standard protocol, which included excision of the infected
graft, intestinal repair, ISR with omental wrap, and long-
term antibiotics. We excluded 8 AGEF patients (13%)
treated with axillofemoral grafts (AXFG, n 5) or femoral
vein grafts (n  3) due to excessive perigraft purulence.
End-points were early morbidity and mortality, and late
survival, reinfection and graft-related complication rates.
Results:There were 45male and 9 female patients with
mean age of 69 9 years. Presentation was gastrointestinal
bleeding in 30 patients, fever in 25, and hemorrhagic shock
in 8. Other features were perigraft fluid/purulence in 42
patients and abscess in 5 (drained in 3). Excision of the
entire graft was required in 38 patients, and 16 had partial
excision to incorporated graft. Total operating time was
6  4 hours. Postoperative complications occurred in 28
patients (52%), and there were 5 deaths (9%), 3 in patients
with shock. The hospital stay was 24  21 days. Five-year
patient survival, primary graft patency, and limb salvage
rates were 66 7%, 88 4% and 100%. There were no late
graft-related deaths. After a median follow-up of 38
months, there was 1 (2%) graft reinfection treated with
AXFG, 3 noninfected femoral aneurysms, and 5 graft limb
thrombosis/restenosis requiring revision.
Conclusions: In situ rifampin-soaked grafts with omen-
tal wrap and long-term antibiotics are associated with low
reinfection rates (2%) in properly selected patients with AGEF
who do not have excessive perigraft purulence. Graft patency
and limb salvage rates are excellent.
Author Disclosures: T. C. Bower: Nothing to disclose;
A. A. Duncan: Nothing to disclose; P. Gloviczki: Noth-
ing to disclose; J. Hofer: Nothing to disclose; M. Kalra:
Nothing to disclose; G. S. Oderich: Cook Medical, Con-
sulting fees or other remuneration (payment) WL Gore,
Consulting fees or other remuneration (payment); J. J.
Ricotta: Nothing to disclose.VS 1.
Video Presentation
Para-visceral Aortic Endarterectomy: Treatment of
Choice for Coral-reef Aortic Plaque
Brian G. DeRubertis, Peter L. Lawrence, William Qui-
nones-Baldrich, Ankur Chandra. Department of Surgery,
UCLA School of Medicine, Los Angeles, CA
Background: While endovascular intervention has sig-
nificantly impacted the treatment of aortic, mesenteric, and
renal arterial occlusive disease, certain disease patterns re-
main best suited for open surgical reconstruction. Eccentric
plaque limited to the para-mesenteric and para-renal aorta
can be effectively treated by retroperitoneal trans-aortic
endarterectomy with excellent results.
Technical Description: A 67-year-old woman pre-
sented with recent onset of bilateral lower extremity
claudication, poorly controlled hypertension, renal in-
sufficiency and several episodes of flash pulmonary
edema. The video presentation includes discussion of the
patient’s clinical presentation and results of her preoper-
ative workup, including magnetic resonance arteriogra-
phy demonstrating occlusive, eccentric and heavily-cal-
cified paramesenteric and pararenal aortic plaque. The
video emphasizes the operative technique for retroperi-
toneal aortic exposure, trap-door aortotomy, and aortic
endarterectomy with complete aortic plaque removal
and reconstruction.
Author Disclosures: A. Chandra: Nothing to disclose;
B. G. DeRubertis: Nothing to disclose; P. F. Lawrence:
Nothing to disclose; W. Quinones-Baldrich: Nothing to
disclose.
SS4.
Secondary Vascular Interventions After EVAR
Brenton E. Quinney, Shardul B. Nagre, Steve M. Taylor,
Marc A. Passman, Mark A. Patterson, Bart R. Combs,
Bruce G. Lowman, William D. Jordan. Vascular Surgery,
University of Alabama at Birmingham, Birmingham, AL
Objectives: Secondary interventions required after pri-
mary endovascular repair of abdominal aortic aneurysms
(EVAR) may affect the short-term benefit of EVAR. This
review details a single-institution 10-year experience with
EVAR to evaluate the impact of secondary interventions on
the clinical utility of EVAR.
Methods: All patients undergoing EVAR were identi-
fied from a prospectively maintained registry. Medical
records were reviewed for outcomes, complications and
secondary vascular interventions.
Results: Between October 1999 and May 2009, 1065
EVAR procedures were performed among 994 patients at
our institution. Within a specifically designed surveillance
protocol which includes computed tomography (CT) scan-
ning and ultrasound, there were 3110 imaging encounters
recorded in 920 patients. Endoleak was identified in 243
